scispace - formally typeset
C

Carolyn C. Gotay

Researcher at University of British Columbia

Publications -  203
Citations -  53687

Carolyn C. Gotay is an academic researcher from University of British Columbia. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 59, co-authored 199 publications receiving 44012 citations. Previous affiliations of Carolyn C. Gotay include BC Cancer Agency & University of Calgary.

Papers
More filters
Journal ArticleDOI

Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials

Andrew Bottomley, +39 more
- 01 Dec 2018 - 
TL;DR: The SISAQOL Consortium will focus on three key priorities in the coming year: developing a taxonomy of research objectives, identifying appropriate statistical methods to analyze patient-reported outcome data, and determining best practices to evaluate and deal with missing data.
Journal ArticleDOI

Assessment of Psychological Functioning in Cancer Patients

TL;DR: This article identified frequently used instruments that have been used to measure psychological functioning in cancer patients, summarizes information about the use of these tools in samples of cancer patients and provides a critical evaluation of and recommendations for developing assessment instruments.
Journal Article

Trial-related quality of life: using quality-of-life assessment to distinguish among cancer therapies.

TL;DR: A model is proposed to identify cognitive, emotional, and sociocultural factors that influence a patient's QOL evaluation and that need to be considered in understanding the meaning of QOL data.
Journal ArticleDOI

Assessing cancer-related quality of life across a spectrum of applications.

TL;DR: Health-related quality of life (HRQOL) is increasingly assessed to understand the effects of cancer and cancer-related interventions, and data can inform individual patient and clinician decision making at the micro level.
Journal ArticleDOI

Toxicity and survival by sex in patients with advanced non-small cell lung carcinoma (NSCLC) on modern Southwest Oncology Group (SWOG) trials

TL;DR: It is suggested that women have better survival than men, possibly due to sex-related changes in drug metabolism based on estrogen levels, according to the older lung cancer clinical trial literature.